With its leading position in Structure-Based Drug Discovery (SBDD), Viva provides state-of-the-art drug research and development services to global biotechnology and pharmaceutical clients for their preclinical, innovative drug discovery programs. We cover the all-around needs of our clients for their early drug research and development, including protein expression, purification and structure determination, hits screening, therapeutic antibody discovery, antibody expression and production, Bioassay, artificial Intelligence drug discovery(AIDD) and computer-aided drug design (CADD), medicinal chemistry and custom synthesis in vivo pharmacology, ADME, and PK studies.
We are committed to providing global pharmaceutical and biotechnology companies with one-stop discovery biology services from target protein preparation to PCC identification. We have a unique biophysical platform with the most advanced biophysical technologies widely used in drug discovery, such as X-ray crystallography, Cryo-EM, ASMS, Intact-MS, Native-MS, HDX-MS, TSA, and SPR. Relying on our advanced technology platform, we efficiently carry out Hit screening, MOA study, Structure-Based Drug Discovery, and Fragment-Based Drug Discovery for global clients, and accelerate innovative drug discovery and development and reduce R&D costs.
Our chemistry services are highly synergized with our discovery biology services and supported by AIDD/CADD drug design platform. We focus on comprehensive, high-quality, and customized chemical synthesis services, including specific technology platforms such as PROTAC molecular synthesis, peptide synthesis, deuterium compounds synthesis, and nucleic acid synthesis.
Customized One-stop Services from Antibody Discovery to Cell Line Development
Viva provides global customers with a full range of PROTAC/Molecular Glue drug discovery services using the world's leading Structure-Based Drug Discovery technology. These services cover biology and chemistry, including protein preparation and crystal structure studies, screening of PROTAC/Molecular Glue, kinetic studies, drug metabolism, medicinal chemistry, Bioassay, AIDD/CADD, and other services.
The Viva XDC Platform is a comprehensive platform created by Viva Biotech. Leveraging extensive expertise in the development of antibody drugs, peptide drugs, and small molecule drugs, it offers clients efficient and high-quality XDC development services.
AIDD and CADD is dedicated to the application of various computer simulation techniques to accelerate drug discovery and design processes, and combines with chemical and biological experiments to drive drug development programs more efficiently. Based on physics, structural chemistry, pharmaceutical chemistry, biochemistry, molecular biology and other disciplines, and based on the theory of quantum chemistry and molecular mechanics, it has developed structure-based drug design with the help of computer numerical calculation and logical judgment, database, graphics, artificial intelligence and other processing technologies.
To learn more about CRO Drug R&D ServicesPlease contact with our service team
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
